Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIST-1: Microdosed Phenylephrine-Tropicamide for Pupil Dilation
NCT03751631Phase 3Completed
- Sponsor
- Hyperion DeFi
- Start
- Nov 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of phenylephrine + atropine in Mydriasis (6 arms), sponsored by Hyperion DeFi. Primary endpoint: Change in Pupil Diameter From Baseline at 35 minutes. Started Nov 2018; status: completed.
02
Drugs
phenylephrine + atropine
03
Conditions
Mydriasis
Beyond the preview
Go deeper on NCT03751631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03751631.